Modified Radical Mastectomy (Mastectomy, Modified)

Subscribe to Selected New Research on Modified Radical Mastectomy

671 relevant articles (21 outcomes, 81 trials/studies) found for this Therapy

Description: Total mastectomy with axillary node dissection, but with preservation of the pectoral muscles.

Also Known As:

Mastectomy, Modified; Radical Mastectomy, Modified; Mastectomy, Modified Radical; Modified Mastectomy; Mastectomies, Modified; Mastectomies, Modified Radical; Mastectomy, Patey; Modified Mastectomies; Modified Radical Mastectomies; Radical Mastectomies, Modified; Patey Mastectomy

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Mastectomy: 4151

Radical Mastectomy: 843

Modified Radical Mastectomy: 671

Experts

1.	Therasse, P: 2 articles (02/2003 - 02/2003)
2.	Legrand, C: 2 articles (02/2003 - 02/2003)
3.	EORTC: 2 articles (02/2003 - 02/2003)
4.	Fentiman, I S: 2 articles (02/2003 - 02/2003)
5.	Yu, James B: 1 article (07/2008)
6.	Castrucci, William A: 1 article (07/2008)
7.	Wilson, Lynn D: 1 article (07/2008)
8.	Dasgupta, Tina: 1 article (07/2008)
9.	Weidhaas, Joanne B: 1 article (07/2008)
10.	Sabato, Alessandro Fabrizio: 1 article (03/2008)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 02/01/2000 - "After four cycles of chemotherapy, the breast cancer was in complete clinical remission, and the patient underwent a modified radical mastectomy with axillary lymph node dissection" 07/01/1994 - "These studies have shown that a modified radical mastectomy is as effective as a radical or extended radical mastectomy for the management of breast cancer" 04/23/1992 - "Breast-conserving surgery followed by radiation therapy is as effective as modified radical mastectomy in treating women with localized breast cancer, as demonstrated by clinical trials reported during the 1980s" 06/01/2000 - "BACKGROUND: Breast conservation surgery (BCS), consisting of lumpectomy, axillary lymph node dissection, and radiation therapy, is as effective as modified radical mastectomy (MRM) for the treatment of early stage breast cancer" 07/01/1997 - "Therefore, it is suggested that our technique of BCT is as effective as modified radical mastectomy in treating operable breast cancer in Japanese patients." Order ALL the reference details at left...
2.	Neoplasms (Cancer) 07/01/1994 - "Modified radical mastectomy without delay is the best option in pregnant patients with Stage I or II and some Stage III cancer" 03/01/2003 - "Modified radical mastectomy should be the gold standard followed by combined adjuvant therapy individualized for patients due to axillary status, tumor size and type." 12/01/1994 - "In recent studies, the many trials to breast conservation therapy reported, such as partial mastectomy plus nodes dissection with or without radiotherapy for selected patients with early cancer represent as effective results as modified mastectomy" 11/01/1992 - "Clinical trials show that T1 breast cancers are equally well treated with breast-conserving surgery as with modified radical mastectomy" 07/01/1989 - "The results of this study therefore indicate that lymphatic cancer cell emboli in the pectoral fascia and muscle are an important risk factor for patients who undergo a modified radical mastectomy." Order ALL the reference details at left...
3.	Carcinoma (Carcinomatosis) 02/01/1979 - "This retrospective study of surgical specimens from forty-three consecutive patients treated by modified radical mastectomy for carcinoma of the breast shows that those patients surviving for at least sixty months after operation have a significantly greater number of mast cells in their axillary lymph nodes than the nonsurvivors (p less than .001)" 07/01/2008 - "BACKGROUND: The role of postmastectomy radiotherapy (PMRT) for lymph node-negative locally advanced breast carcinoma (T3N0M0) after modified radical mastectomy (MRM) with regard to improvement in survival remains an area of controversy" 04/01/2005 - "PATIENTS AND METHODS: Criteria for including patients in this study was female patients with stage II and III carcinoma breast who presented in our unit from 1995-2002 and underwent surgical (modified radical mastectomy, simple mastectomy with axillary sampling) and non-surgical (chemotherapy, radiotherapy, hormonal therapy) treatment of carcinoma breast" 02/01/2003 - "Of note, 53% of women with breast carcinoma had breast-conserving surgery and 45% had modified radical mastectomy in this study; 71% had radical or modified radical mastectomy in the earlier report" 07/01/1997 - "BACKGROUND: Although the conclusions reached in the National Surgical Adjuvant Bowel and Breast Protocol B-06 trial and other clinical trials appear to remain intact, questions persist regarding the equivalency of breast preservation compared with modified radical mastectomy for patients with invasive carcinoma" Order ALL the reference details at left...
4.	Neoplasm Metastasis (Metastasis) 11/01/1985 - "Ten cases of apparent isolated metastasis in the pectoralis muscle following modified radical mastectomy are presented and good results were obtained in some cases utilizing surgery or x-ray therapy or a combination" 02/01/2003 - "Eight patients had macroscopic nodal metastases and underwent a delayed modified radical mastectomy and immediate reconstruction" 08/01/2002 - "The second recurrence involved a distant metastasis in a patient treated with modified radical mastectomy that eventually led to her death" 06/01/2002 - "Local recurrence rates and the incidence of distant metastasis are not increased compared with those of patients who have had modified radical mastectomies without reconstruction." 08/01/2001 - "Two patients who underwent modified radical mastectomy developed lung metastases within 2 years after the initial diagnosis" Order ALL the reference details at left...
5.	Noninfiltrating Intraductal Carcinoma (DCIS) 07/01/2003 - "Our data revealed that the percentage of the DCIS patients who received a lumpectomy increased from 34.3% in 1988-1991 to 53.7% in 1996-1999 in Louisiana (p<0.05) while DCIS patients who received a modified radical mastectomy decreased from 51.7% to 26.1% (p<0.05)" 05/01/2000 - "This was carried out for this patient following a modified radical mastectomy for stage III (T2b, N2, M0) intraductal carcinoma of the breast" 12/01/1997 - "Total mastectomy was the most common form of treatment for DCIS (19 cases, 34.5%) during this period, followed by modified radical mastectomy, lumpectomy only, lumpectomy with radiation therapy" 03/01/1991 - "During a ten year period, 175 axillary lymph node dissections were done as part of the treatment for intraductal carcinoma of the breast; 98 patients were treated with modified radical mastectomy and 77 were treated by mammary preservation, consisting of excision of the lesion, axillary dissection and radiation therapy" 11/01/1988 - "Five of the patients underwent a modified radical mastectomy; histologic study of the excision specimens showed three invasive ductal carcinomas and two intraductal carcinomas" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cyclophosphamide (Cytoxan)
2.	Ondansetron (Zofran)
3.	Granisetron (Kytril)
4.	Fluorouracil (Carac)
5.	Epirubicin (Ellence)
6.	Amifostine (Ethyol)
7.	dexon (fungicide)
8.	Tamoxifen
9.	Doxorubicin (Adriamycin)
10.	Silicones

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Segmental Mastectomy (Lumpectomy)
3.	Lymph Node Excision (Lymph Node Dissection)
4.	Radical Mastectomy
5.	Mastectomy (Mammectomy)

Best Treatments:
Research Summary Report
on Breast Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3579 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>